Di Xie Selected Research

Clemastine (Clemastine Fumarate)

1/2022	Clemastine protects against sepsis-induced myocardial injury in vivo and in vitro.
2/2020	Clemastine improves hypomyelination in rats with hypoxic-ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Di Xie Research Topics

Disease

9	Chronic Renal Insufficiency 11/2021 - 01/2006
7	Proteinuria 11/2021 - 01/2006
6	Neoplasms (Cancer) 01/2021 - 12/2016
6	Inflammation (Inflammations) 01/2012 - 05/2006
5	Type 2 Diabetes Mellitus (MODY) 03/2022 - 01/2010
5	Albuminuria 11/2021 - 04/2008
5	Stroke (Strokes) 01/2021 - 02/2015
5	Atherosclerosis 03/2015 - 05/2006
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2014 - 01/2006
3	Hypertension (High Blood Pressure) 11/2021 - 01/2015
3	Hypertrophy 10/2018 - 02/2007
3	Renal Insufficiency (Renal Failure) 07/2011 - 01/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2010 - 12/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2022 - 01/2022
2	Abdominal Obesity 03/2022 - 08/2015
2	Obesity 03/2022 - 08/2015
2	Sepsis (Septicemia) 01/2022 - 05/2016
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 12/2020
2	Fibrosis (Cirrhosis) 01/2020 - 02/2007
2	Hypoxia (Hypoxemia) 11/2019 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 05/2017
2	Esophageal Neoplasms (Esophageal Cancer) 01/2018 - 05/2017
2	Breast Neoplasms (Breast Cancer) 01/2018 - 05/2017
2	Neuroinflammatory Diseases 12/2016 - 05/2016
2	Kidney Diseases (Kidney Disease) 10/2013 - 07/2011
2	Anemia 10/2012 - 06/2006
1	Infections 01/2022
1	Hyperglycemia 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Gastroenteritis 01/2022
1	Tuberous Sclerosis 1 12/2021
1	Cardiotoxicity 12/2021
1	Ischemic Stroke 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Lung Injury 01/2021
1	Brain Injuries (Brain Injury) 02/2020
1	Carcinogenesis 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2020
1	Heart Failure 01/2020

Drug/Important Bio-Agent (IBA)

9	Advanced Oxidation Protein Products (AOPP)IBA 10/2010 - 05/2006
6	CreatinineIBA 11/2021 - 01/2006
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2007
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2010 - 04/2008
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 10/2013
3	HDL LipoproteinsIBA 03/2015 - 01/2012
3	benazepril (Briem)FDA LinkGeneric 07/2011 - 01/2006
2	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2022
2	HDL CholesterolIBA 03/2022 - 08/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2015
2	Clemastine (Clemastine Fumarate)FDA LinkGeneric 01/2022 - 02/2020
2	Interleukin-33IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 12/2021 - 01/2020
2	AlbuminsIBA 11/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2020
2	Alkaline PhosphataseIBA 01/2021 - 01/2021
2	Enalapril FDA LinkGeneric 01/2021 - 01/2015
2	salicylhydroxamic acid (SHAM)IBA 12/2020 - 02/2007
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 10/2018
2	Biological ProductsIBA 09/2019 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2018 - 05/2017
2	LipopolysaccharidesIBA 12/2016 - 05/2016
2	CytokinesIBA 05/2016 - 06/2013
2	ORALIT (ORS)IBA 08/2015 - 04/2015
2	HomocysteineIBA 02/2015 - 10/2013
2	Losartan (Cozaar)FDA LinkGeneric 07/2011 - 06/2007
2	acetovanillone (apocynin)IBA 01/2010 - 12/2009
2	Serum AlbuminIBA 01/2010 - 12/2009
2	Ethanol (Ethyl Alcohol)IBA 08/2009 - 03/2009
2	oxidized low density lipoproteinIBA 08/2009 - 05/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022
1	Triglycerides (Triacylglycerol)IBA 03/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	VaccinesIBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 12/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2021
1	Endothelin Receptor AntagonistsIBA 11/2021
1	hydroxide ionIBA 11/2021
1	Calcifediol (Calcidiol)FDA Link 11/2021
1	AtrasentanIBA 11/2021
1	PLX5622IBA 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	STAT6 Transcription FactorIBA 01/2021
1	OsteopontinIBA 01/2021
1	LipidsIBA 01/2020
1	CollagenIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	alpha-galactosylceramideIBA 01/2020
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2020
1	empagliflozinIBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2006
3	Immunotherapy 01/2021 - 12/2016
1	Phototherapy (Light Therapy) 01/2021
1	Continuous Renal Replacement Therapy 01/2020